Customize your search results with filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 04/25/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4534 publications
The time has come for an integrated and multiscale grading system for oligodendrogliomas IDH-mutant and 1p/19q co-deleted mixing imaging and histomolecular parameters.
Journal: Neuro-oncology
Published: April 17, 2025
Cytology and histology of a high-grade oligodendroglioma with embryonal features in a dog.
Journal: Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc
Published: April 16, 2025
Spatial synaptic connectivity underlies oligodendroglioma evolution and recurrence.
Journal: Research square
Published: April 16, 2025
Current trends in the allocation of National Institute of Health funding of brain tumor research.
Journal: Neuro-oncology advances
Published: April 07, 2025
The capability to successfully study and to be graduated in students who underwent awake surgical resection for a low-grade glioma.
Journal: Journal of neuro-oncology
Published: March 23, 2025
Trends in the Incidence of Cancer Among Adolescents and Young Adults Between 2000 and 2020: A Study Based on French Population-Based Registry Data.
Journal: Journal of adolescent and young adult oncology
Published: March 17, 2025
Functional connectivity between tumor region and resting-state networks as imaging biomarker for overall survival in recurrent gliomas diagnosed by O-(2-[18F]fluoroethyl)-l-tyrosine PET.
Journal: Neuro-oncology advances
Published: March 14, 2025
Oligosarcoma with chondroid metaplasia in a French bulldog.
Journal: The Journal of veterinary medical science
Published: March 12, 2025
Survival prediction with radiomics for patients with IDH mutated lower-grade glioma.
Journal: Journal of neuro-oncology
Published: February 13, 2025
A single-arm phase 2 study of abemaciclib in adult patients with recurrent grade 3 oligodendroglioma.
Journal: Neuro-oncology advances
Published: February 13, 2025
Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomes.
Journal: Neuro-oncology advances
Published: February 06, 2025
Last Updated: 04/25/2025